Medical use of cannabinoids

AI Fraguas-Sánchez, AI Torres-Suárez - Drugs, 2018 - Springer
Cannabinoid receptors, endocannabinoids and the enzymes responsible for their
biosynthesis and degradation constitute the endocannabinoid system. In recent decades …

[HTML][HTML] Cannabinoids and epilepsy

EC Rosenberg, RW Tsien, BJ Whalley, O Devinsky - Neurotherapeutics, 2015 - Elsevier
Cannabis has been used for centuries to treat seizures. Recent anecdotal reports,
accumulating animal model data, and mechanistic insights have raised interest in cannabis …

Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases

C Chen - Pharmacology & therapeutics, 2023 - Elsevier
Endocannabinoids are endogenous lipid signaling mediators that participate in a variety of
physiological and pathological processes. 2-Arachidonoylglycerol (2-AG) is the most …

Enhanced endocannabinoid tone as a potential target of pharmacotherapy

M Toczek, B Malinowska - Life sciences, 2018 - Elsevier
The endocannabinoid system is up-regulated in numerous pathophysiological states such
as inflammatory, neurodegenerative, gastrointestinal, metabolic and cardiovascular …

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists

M Aghazadeh Tabrizi, PG Baraldi, PA Borea… - Chemical …, 2016 - ACS Publications
The endocannabinoid system is represented by a group of neuromodulatory lipids and their
receptors that are involved in a variety of physiological and pathological conditions. The …

Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a …

F Tchantchou, Y Zhang - Journal of neurotrauma, 2013 - liebertpub.com
arachidonylglycerol (2-AG) is the most abundant endocannabinoid in the central nervous
system and is elevated after brain injury. Because of its rapid hydrolysis, however, the …

The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain …

F Tchantchou, LB Tucker, AH Fu, RJ Bluett… - …, 2014 - Elsevier
Traumatic brain injury (TBI) is the leading cause of death in young adults in the United
States, but there is still no effective agent for treatment. N-arachidonoylethanolamine …

Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications

RG Pertwee - Proceedings of the Nutrition Society, 2014 - cambridge.org
The endocannabinoid system consists of cannabinoid CB1 and CB2 receptors, of
endogenous agonists for these receptors known as 'endocannabinoids', and of processes …

Possible therapeutic applications of cannabis in the neuropsychopharmacology field

J Fernández-Ruiz, I Galve-Roperh, O Sagredo… - European …, 2020 - Elsevier
Cannabis use induces a plethora of actions on the CNS via its active chemical ingredients,
the so-called phytocannabinoids. These compounds have been frequently associated with …

Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC

JMJ Oultram, JL Pegler, TA Bowser, LJ Ney… - Biomedicines, 2021 - mdpi.com
Cannabis sativa (Cannabis) is one of the world's most well-known, yet maligned plant
species. However, significant recent research is starting to unveil the potential of Cannabis …